148 related articles for article (PubMed ID: 16232198)
21. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
22. Targeted next-generation sequencing for analyzing the genetic alterations in atypical adenomatous hyperplasia and adenocarcinoma in situ.
Xu X; Li N; Zhao R; Zhu L; Shao J; Zhang J
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2447-2453. PubMed ID: 28821955
[TBL] [Abstract][Full Text] [Related]
23. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.
Kitamura H; Kameda Y; Nakamura N; Nakatani Y; Inayama Y; Iida M; Noda K; Ogawa N; Shibagaki T; Kanisawa M
Am J Pathol; 1995 Apr; 146(4):876-87. PubMed ID: 7717455
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
[TBL] [Abstract][Full Text] [Related]
25. Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
Rehman I; Cross SS; Catto JW; Leiblich A; Mukherjee A; Azzouzi AR; Leung HY; Hamdy FC
Prostate; 2005 Dec; 65(4):322-30. PubMed ID: 16015609
[TBL] [Abstract][Full Text] [Related]
26. Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma?
Ullmann R; Bongiovanni M; Halbwedl I; Fraire AE; Cagle PT; Mori M; Papotti M; Popper HH
J Pathol; 2003 Nov; 201(3):371-6. PubMed ID: 14595748
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Dicer in precursor lesions of lung adenocarcinoma.
Chiosea S; Jelezcova E; Chandran U; Luo J; Mantha G; Sobol RW; Dacic S
Cancer Res; 2007 Mar; 67(5):2345-50. PubMed ID: 17332367
[TBL] [Abstract][Full Text] [Related]
28. Expression of calcium-binding protein S100A2 in breast lesions.
Liu D; Rudland PS; Sibson DR; Platt-Higgins A; Barraclough R
Br J Cancer; 2000 Dec; 83(11):1473-9. PubMed ID: 11076656
[TBL] [Abstract][Full Text] [Related]
29. Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E; Koering CE; Gilson E
Clin Cancer Res; 2003 Mar; 9(3):1105-11. PubMed ID: 12631614
[TBL] [Abstract][Full Text] [Related]
30. S100A2 induces metastasis in non-small cell lung cancer.
Bulk E; Sargin B; Krug U; Hascher A; Jun Y; Knop M; Kerkhoff C; Gerke V; Liersch R; Mesters RM; Hotfilder M; Marra A; Koschmieder S; Dugas M; Berdel WE; Serve H; Müller-Tidow C
Clin Cancer Res; 2009 Jan; 15(1):22-9. PubMed ID: 19118029
[TBL] [Abstract][Full Text] [Related]
31. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.
Mori M; Rao SK; Popper HH; Cagle PT; Fraire AE
Mod Pathol; 2001 Feb; 14(2):72-84. PubMed ID: 11235908
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical detection of XIAP and p63 in adenomatous hyperplasia, atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and well-differentiated adenocarcinoma.
Wu M; Orta L; Gil J; Li G; Hu A; Burstein DE
Mod Pathol; 2008 May; 21(5):553-8. PubMed ID: 18432259
[TBL] [Abstract][Full Text] [Related]
33. The significance of associated pre-invasive lesions in patients resected for primary lung neoplasms.
Ruffini E; Bongiovanni M; Cavallo A; Filosso PL; Giobbe R; Mancuso M; Molinatti M; Oliaro A
Eur J Cardiothorac Surg; 2004 Jul; 26(1):165-72. PubMed ID: 15200997
[TBL] [Abstract][Full Text] [Related]
34. The expression of COX-2, hTERT, MDM2, LATS2 and S100A2 in different types of non-small cell lung cancer (NSCLC).
Strazisar M; Mlakar V; Glavac D
Cell Mol Biol Lett; 2009; 14(3):442-56. PubMed ID: 19238334
[TBL] [Abstract][Full Text] [Related]
35. The prognosis of resected lung carcinoma associated with atypical adenomatous hyperplasia: a comparison of the prognosis of well-differentiated adenocarcinoma associated with atypical adenomatous hyperplasia and intrapulmonary metastasis.
Suzuki K; Nagai K; Yoshida J; Yokose T; Kodama T; Takahashi K; Nishimura M; Kawasaki H; Yokozaki M; Nishiwaki Y
Cancer; 1997 Apr; 79(8):1521-6. PubMed ID: 9118033
[TBL] [Abstract][Full Text] [Related]
36. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
[TBL] [Abstract][Full Text] [Related]
37. Atypical goblet cell hyperplasia in congenital cystic adenomatoid malformation as a possible preneoplasia for pulmonary adenocarcinoma in childhood: A genetic analysis.
Stacher E; Ullmann R; Halbwedl I; Gogg-Kammerer M; Boccon-Gibod L; Nicholson AG; Sheppard MN; Carvalho L; Franca MT; Macsweeney F; Morresi-Hauf A; Popper HH
Hum Pathol; 2004 May; 35(5):565-70. PubMed ID: 15138930
[TBL] [Abstract][Full Text] [Related]
38. Survivin expression in atypical adenomatous hyperplasia of the lung.
Nakanishi K; Kawai T; Kumaki F; Hiroi S; Mukai M; Ikeda E
Am J Clin Pathol; 2003 Nov; 120(5):712-9. PubMed ID: 14608897
[TBL] [Abstract][Full Text] [Related]
39. Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung.
Sivakumar S; San Lucas FA; Jakubek YA; McDowell TL; Lang W; Kallsen N; Peyton S; Davies GE; Fukuoka J; Yatabe Y; Zhang J; Futreal PA; Fowler J; Fujimoto J; Ehli EA; Hawk ET; Wistuba II; Kadara H; Scheet P
EBioMedicine; 2019 Apr; 42():296-303. PubMed ID: 30905849
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma.
Sato T; Arai E; Kohno T; Tsuta K; Watanabe S; Soejima K; Betsuyaku T; Kanai Y
PLoS One; 2013; 8(3):e59444. PubMed ID: 23544068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
